Estima Pharmaceuticals Private Limited
Rajarajeshwari Nagara, Karnataka
In their own words
Set Up of Greenfield Manufacturing Facility - General Injectable products (Nature of the project is to produce sterile dosage pharmaceutical products with in-depth pharmaceutical and engineering knowledge. Capabilities: • EU GMP and USFDA compliant plant for Small Volume Parenterals (SVP) with Liquid Injections, Lyophilized injections, Suspension and Emulsion Injections, Terminally sterilized Liquid Injectable products, Packaging facility as per international Regulatory and cGMP standards, proposed. Target is to produce approximately 35 - 40 million units/year of different formulations and products over the next 3-4 years outlay. Proposed Location 10-15 acres industrial area around Mysore, Karnataka – India Research & Development Facility – (Standalone) To be designed at Bangalore, India on a 25,000 Sq. Ft space Type Of Products For Development Liquid Injections, Lyophilized Injectable Products, Liquid Injections With Terminal Sterilisation, Suspension & Emulsion Injectables, Pre - Filled Syringes Ampoules Financial Highlights: Project cost - ~ US$ 120 Million Investment requested - US $ 115 million as debt funding (reducing balance), Debt repayment in 5 years with moratorium of 18 months from commencing commercial production, Sales earmark in 2025 - US$ 49 million, US$ 761 million by 2034, EBIDTA in 2025 US$ 1.10 million, US $ 173.59 million by 2034 Cumulative cash balance is US$ 705.44 million by 2034. Profitability Projection Manufacturing facility tentatively to be operational by 2024; revenue to appear on books from 2025 with EBIDTA expected to open conservatively at 20-30% on the net sales – (YoY). Project Costing: Plant With R&D (Cost In Usd Million) Land 2.00, Building 4.00, Plant & Equipments 62.00, Product Development 40.00, Professional Fees 4.00 Pre & Post-Operational Expenses 8.00, Total Project Cost 120.00 Budget allocation for Manufacturing Facility: (Under Debt) US$ 65 Million spread over February 2022 through March 2023 Budget Allocation for R&D Facility: (Under Debt) US$ 50 Million spread over January 2022 through October 2023; US$ 5 Million – Seed capital for entire project
Written by the company on its public Startup India profile. Not verified by us.
What the record says
- DPIIT recognition number
- DIPP107427
- CIN
- U24299KA2022PTC159912
- Incorporated (MCA)
- 2022
- Registered on Startup India
- 2022
- Self-declared stage
- Prototype
- MCA status
- Active
- Company class
- Private
- Registrar
- RoC-Bangalore
- Authorised capital
- ₹15,00,000
- Paid-up capital
- ₹10,00,000
Funding signals
We hold evidence classes, not rounds. There is no amount, no date and no valuation here because we do not have them.
- Self-declared on the government form, unverified
Where this is
Locality
Rajarajeshwari Nagara
Karnataka
We know the area, Rajarajeshwari Nagara, but not the address. The pin below covers roughly a kilometre.
Geocode confidence: medium
What we do not know
- no website on file
We have no liveness signal for any company on this site: no filings feed, no revenue, no check that the website still resolves. A record existing here means a record exists, not that a business is trading.
Is this your company?
Everything here comes from public government records. If something is wrong, the authoritative place to correct it is the Startup India portal itself, and we will pick the correction up on the next monthly snapshot. To flag an error on our side, write to trust@indianstartupmap.com.